Getty Images (GETY) Q4 2025 Earnings Transcript

Getty reported record FY2025 revenue of $981.3M (up 4.5%) and adjusted EBITDA of $320.9M (up 6.9%), with Q4 revenue $282.3M (+14.1%) and Q4 adjusted EBITDA $104.1M (+29.1%). Two multiyear licensing deals accelerated ~$40M of Q4 revenue (total deal value ~$65M; ~$15M expected in 2026), driving the outperformance but creating a tougher 2026 comp: guidance of $948M–$988M in revenue (down 3.4% to up 0.6%) and $279M–$295M adjusted EBITDA (down 12.9% to 8.1%) is primarily timing-driven. Liquidity/credit risk notable: year-end cash $90.2M, total debt $2.01B, net leverage ~4.0x, FY free cash flow just $5.7M (vs $60.9M prior) after merger/refinancing costs and elevated interest expense; UK regulatory clearance for the Shutterstock deal remains pending (CMA decision expected in June).

Analysis

The headline math from the quarter is a classic timing-driven story: lumpy, contract-driven cash flows created an illusion of outsized momentum that will mechanically invert in the next fiscal period. That dynamic tends to compress multiples in the near term despite recurring subscription and content demand remaining intact, creating a windows-of-opportunity trade for patient capital that can distinguish transient recognition effects from underlying cash generation.

Regulatory and capital-structure friction are the underappreciated second-order risks. A near-term UK regulatory decision on the pending combination and the presence of expensive, deal-related financing held in escrow materially raise the cost of being patient: failure or delay forces either a strategic fallback (asset carve-outs/sale process) or stretched liquidity decisions that will disproportionately penalize equity holders versus bondholders.

On AI/licensing the company’s editorial “do-not-license” stance is a double-edged sword: it preserves scarcity and negotiating leverage for bespoke, high-margin deals, but it also increases reliance on a smaller set of large partners and raises enforcement and litigation vectors as scraped datasets proliferate. Regionally, APAC agency weakness signals that recovery will require product and commercial fixes (localized pricing, reseller re-org) rather than simple macro improvements — meaning timing of global revenue normalization is uncertain and asymmetric by geography.

Practical implication: play the headline-induced volatility around two mid- to near-term catalysts (regulatory outcome and next quarterly cadence of licensing recognition) with defined-risk option structures or pair trades that isolate operational momentum from event risk. Credit-sensitive strategies and volatility sells are attractive where yield compensates for deal execution uncertainty, but only with clear stop-losses tied to regulatory readouts.

Key Decisions for Investors

• Long GETY equity with protective puts: Buy GETY stock and purchase a 3–6 month put (or a put spread) to cap downside through the near-term UK regulatory readout; target 30–50% upside if licensing narrative re-prices; downside protected to ~10–15% via the hedge.
• Call-spread directional: Purchase a 9–12 month GETY call spread (buy nearer-dated call, sell higher strike) to play mean reversion after multiple compression caused by revenue-recognition comps; limited premium outlay and convex upside if the merger clears or new licensing deals are announced.
• Pair trade (earnings-arbitrage): Long GETY equity / short SSTK equity for 3–9 months to express confidence in Getty’s monetization leverage from AI licensing vs. continued regulatory/execution risk for the acquirer; size small relative to book, stop if UK regulator signals benign outcome or if spread tightens by >25%.
• Credit hedge: Buy short-dated credit protection (or underweight HY paper) on Getty’s merger-related bonds for a 6–12 month horizon to monetize elevated refinancing/execution risk; asymmetry: limited premium today versus sizable price move if the merger falters or covenant pressure materializes.